Prevalence of gastric precursor lesions in countries with differential gastric cancer burden: A systematic review and meta-analysis Journal Article


Authors: Mülder, D. T.; Hahn, A. I.; Huang, R. J.; Zhou, M. J.; Blake, B.; Omofuma, O.; Murphy, J. D.; Gutiérrez-Torres, D. S.; Zauber, A. G.; O'Mahony, J. F.; Camargo, M. C.; Ladabaum, U.; Yeh, J. M.; Hur, C.; Lansdorp-Vogelaar, I.; Meester, R.; Laszkowska, M.
Article Title: Prevalence of gastric precursor lesions in countries with differential gastric cancer burden: A systematic review and meta-analysis
Abstract: Background & Aims: The prevalence of precursor lesions for gastric cancer (GC) and the differential burden between countries of varying GC risk is not well-understood. We conducted a systematic review and meta-analysis to estimate the global prevalence of precursor lesions. Methods: We estimated the prevalence of atrophic gastritis (AG), gastric intestinal metaplasia (IM), and dysplasia in regions with low, medium, and high GC incidence. Because IM is an advanced manifestation of AG, we assessed the prevalence of less advanced precursors, regardless of the presence of more advanced lesions. Prevalence was sub-stratified by Helicobacter pylori infection, symptomatology, and period (<2000, 2000–2010, and >2010). Results: Among the 582 articles that underwent full-text review, 166 studies met inclusion criteria. The global prevalence estimates of AG, IM, and dysplasia were 25.4%, 16.2%, and 2.0%, respectively, on the basis of 126 studies that reported the prevalence of less advanced precursors, regardless of the presence of more advanced lesions. The prevalence of all precursor lesions was higher in high and medium compared with low GC incidence countries (P < .01). Prevalence of AG and IM was significantly higher among H pylori–infected individuals (P < .01) but not statistically different between symptomatic and asymptomatic individuals (P > .17). All precursors demonstrated a secular decrease in prevalence over time. Conclusions: Gastric precursor lesions have differences in prevalence in regions with differential GC incidence and are associated with H pylori infection. Because of the substantial prevalence of precursor lesions in both symptomatic and asymptomatic individuals, symptomatic evaluation may not be sufficient to identify individuals at risk. These estimates provide important insights for tailoring GC prevention strategies. © 2024 AGA Institute
Keywords: metaplasia; sensitivity analysis; vomiting; prevalence; pathology; risk factor; histology; abdominal pain; systematic review; stomach cancer; health care system; symptomatology; epidemiology; stomach neoplasms; gastrointestinal endoscopy; ethnicity; helicobacter infections; helicobacter pylori; meta analysis; stomach tumor; dysplasia; gastric cancer; precancerous conditions; randomized controlled trial (topic); global health; bloating; precancer; helicobacter infection; stomach mucosa; intestinal metaplasia; disease burden; humans; human; article; atrophic gastritis; dispersity; gastritis, atrophic; intestinal metaplasia of the stomach; gastric precursor lesions; global burden atrophic gastritis; meta-analyses
Journal Title: Clinical Gastroenterology and Hepatology
Volume: 22
Issue: 8
ISSN: 1542-3565
Publisher: Elsevier Science, Inc.  
Date Published: 2024-08-01
Start Page: 1605
End Page: 1617.e46
Language: English
DOI: 10.1016/j.cgh.2024.02.023
PUBMED: 38438000
PROVIDER: scopus
PMCID: PMC11272442
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors is MSK author: Monika Laszkowska -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ann G Zauber
    314 Zauber
  2. Anne Impellizeri Hahn
    17 Hahn